Back to Journals » International Journal of Women's Health » Volume 4
Overcoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophy
Authors Chism L
Received 17 July 2012
Accepted for publication 22 August 2012
Published 12 October 2012 Volume 2012:4 Pages 551—557
DOI https://doi.org/10.2147/IJWH.S36026
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Lisa A Chism
Karmanos Cancer Institute, Alexander J Walt Comprehensive Breast Center, Detroit, Michigan, USA
Abstract: The purpose of this review is to summarize current information regarding the pathophysiology and management of vaginal atrophy (sometimes called “atrophic vaginitis”) and to identify barriers to its treatment with local (or “topical”) vaginal estrogen therapy. Relevant clinical trials, meta-analyses, and reviews were identified through the PubMed database. Local estrogen therapy is effective and safe for treatment of vaginal atrophy; however, barriers to treatment (eg, patient reluctance to discuss the condition, misinformation, incomplete understanding of the effectiveness and safety of available therapies) result in its underuse. Health care providers can help overcome barriers to effective treatment of vaginal atrophy by facilitating discussion with women about vaginal health. Discussions should occur at routine preventive health care examinations and during episodic visits when patients present with symptoms of vaginal atrophy. Education and counseling should include information on the importance of maintaining vaginal health and the benefits and risks of treatment, including the demonstrated effectiveness and safety profile of low-dose local estrogen therapy.
Keywords: atrophic vaginitis, vaginal health, hormone therapy, local estrogen
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.